| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli | 44 | 2023 | 1305 | 4.840 |
Why?
|
| Stress, Physiological | 9 | 2018 | 493 | 2.110 |
Why?
|
| Mutagenesis | 18 | 2023 | 519 | 2.070 |
Why?
|
| Escherichia coli Proteins | 18 | 2023 | 377 | 1.810 |
Why?
|
| DNA Repair | 23 | 2019 | 1910 | 1.490 |
Why?
|
| Recombination, Genetic | 20 | 2019 | 665 | 1.450 |
Why?
|
| Models, Genetic | 17 | 2019 | 1164 | 1.050 |
Why?
|
| DNA Replication | 11 | 2021 | 771 | 1.050 |
Why?
|
| Lac Operon | 11 | 2011 | 133 | 1.010 |
Why?
|
| DNA Damage | 13 | 2019 | 1988 | 1.000 |
Why?
|
| Chromosomes, Bacterial | 6 | 2015 | 69 | 1.000 |
Why?
|
| Genomic Instability | 8 | 2024 | 521 | 0.990 |
Why?
|
| Gene Amplification | 7 | 2012 | 766 | 0.930 |
Why?
|
| DNA Copy Number Variations | 8 | 2022 | 1568 | 0.900 |
Why?
|
| DNA Breaks, Double-Stranded | 12 | 2024 | 327 | 0.710 |
Why?
|
| Adaptation, Physiological | 5 | 2004 | 346 | 0.710 |
Why?
|
| Adaptation, Biological | 5 | 2007 | 48 | 0.680 |
Why?
|
| Sigma Factor | 5 | 2019 | 43 | 0.660 |
Why?
|
| Evolution, Molecular | 11 | 2012 | 867 | 0.650 |
Why?
|
| Mutation | 25 | 2023 | 15911 | 0.630 |
Why?
|
| Point Mutation | 7 | 2013 | 788 | 0.620 |
Why?
|
| Bacterial Proteins | 10 | 2019 | 1092 | 0.610 |
Why?
|
| Gene Dosage | 4 | 2011 | 823 | 0.600 |
Why?
|
| Nucleic Acid Heteroduplexes | 2 | 2013 | 28 | 0.570 |
Why?
|
| Biological Evolution | 3 | 2011 | 290 | 0.550 |
Why?
|
| DNA-Directed DNA Polymerase | 4 | 2019 | 199 | 0.540 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2024 | 470 | 0.500 |
Why?
|
| DNA Polymerase beta | 3 | 2010 | 20 | 0.500 |
Why?
|
| Gene Rearrangement | 7 | 2019 | 813 | 0.490 |
Why?
|
| Perciformes | 2 | 2011 | 6 | 0.480 |
Why?
|
| Gene Expression Regulation, Bacterial | 7 | 2023 | 205 | 0.460 |
Why?
|
| DNA Breaks, Single-Stranded | 2 | 2016 | 27 | 0.460 |
Why?
|
| RNA | 2 | 2023 | 1064 | 0.460 |
Why?
|
| DNA Polymerase II | 2 | 2010 | 58 | 0.440 |
Why?
|
| Chromosomes, Fungal | 2 | 2012 | 56 | 0.440 |
Why?
|
| Selection, Genetic | 4 | 2012 | 198 | 0.430 |
Why?
|
| DNA, Bacterial | 9 | 2016 | 606 | 0.420 |
Why?
|
| DNA Replication Timing | 1 | 2011 | 13 | 0.400 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2024 | 662 | 0.390 |
Why?
|
| Chromosomal Instability | 2 | 2019 | 229 | 0.390 |
Why?
|
| Anti-Bacterial Agents | 5 | 2023 | 3181 | 0.360 |
Why?
|
| DNA | 9 | 2023 | 3051 | 0.350 |
Why?
|
| Clonal Evolution | 1 | 2011 | 250 | 0.340 |
Why?
|
| Sequence Homology | 1 | 2009 | 76 | 0.330 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 466 | 0.310 |
Why?
|
| Chromosome Aberrations | 2 | 2011 | 2031 | 0.290 |
Why?
|
| DNA, Mitochondrial | 2 | 2024 | 315 | 0.290 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 1280 | 0.290 |
Why?
|
| DNA-Binding Proteins | 7 | 2022 | 5002 | 0.280 |
Why?
|
| Reactive Oxygen Species | 4 | 2022 | 1006 | 0.270 |
Why?
|
| Oxidative Stress | 4 | 2007 | 1149 | 0.270 |
Why?
|
| Chromatin | 1 | 2011 | 1046 | 0.260 |
Why?
|
| Crossing Over, Genetic | 3 | 2011 | 65 | 0.250 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2019 | 426 | 0.250 |
Why?
|
| Retroelements | 1 | 2024 | 52 | 0.240 |
Why?
|
| Heat-Shock Response | 1 | 2004 | 41 | 0.240 |
Why?
|
| Genetic Variation | 2 | 2013 | 2165 | 0.230 |
Why?
|
| Drug Resistance, Microbial | 4 | 2023 | 243 | 0.220 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 2115 | 0.220 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 6686 | 0.220 |
Why?
|
| DNA, Cruciform | 3 | 2021 | 19 | 0.210 |
Why?
|
| Drug Resistance | 1 | 2004 | 610 | 0.210 |
Why?
|
| Caenorhabditis elegans | 1 | 2004 | 280 | 0.200 |
Why?
|
| Base Sequence | 9 | 2015 | 5437 | 0.200 |
Why?
|
| Chromosome Fragility | 1 | 2021 | 33 | 0.190 |
Why?
|
| Bacteriophage mu | 2 | 2018 | 14 | 0.190 |
Why?
|
| Thymine | 2 | 2011 | 45 | 0.180 |
Why?
|
| Genome | 1 | 2004 | 690 | 0.180 |
Why?
|
| DNA End-Joining Repair | 3 | 2024 | 92 | 0.180 |
Why?
|
| Viral Proteins | 2 | 2013 | 491 | 0.180 |
Why?
|
| Frameshift Mutation | 4 | 2013 | 234 | 0.180 |
Why?
|
| Chromosomes | 1 | 2000 | 324 | 0.170 |
Why?
|
| Comparative Genomic Hybridization | 4 | 2022 | 691 | 0.160 |
Why?
|
| Rec A Recombinases | 3 | 2010 | 32 | 0.160 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2018 | 58 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2019 | 668 | 0.160 |
Why?
|
| DNA, Fungal | 2 | 1996 | 144 | 0.150 |
Why?
|
| DNA Polymerase I | 2 | 2010 | 30 | 0.150 |
Why?
|
| RecQ Helicases | 2 | 2016 | 95 | 0.150 |
Why?
|
| Deoxyguanine Nucleotides | 1 | 2017 | 22 | 0.150 |
Why?
|
| Mutagenesis, Insertional | 2 | 2015 | 219 | 0.140 |
Why?
|
| Genome, Bacterial | 2 | 2015 | 213 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 469 | 0.130 |
Why?
|
| Genome, Human | 3 | 2019 | 1886 | 0.130 |
Why?
|
| Exodeoxyribonucleases | 4 | 2011 | 109 | 0.130 |
Why?
|
| Phenotype | 6 | 2015 | 6516 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 5 | 2019 | 2573 | 0.130 |
Why?
|
| Neoplasms | 5 | 2021 | 15919 | 0.130 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 304 | 0.120 |
Why?
|
| Uniparental Disomy | 1 | 2015 | 63 | 0.120 |
Why?
|
| Gene Library | 1 | 2015 | 353 | 0.120 |
Why?
|
| Genomics | 3 | 2015 | 2836 | 0.120 |
Why?
|
| Genes, Bacterial | 2 | 2006 | 270 | 0.120 |
Why?
|
| DNA Helicases | 3 | 2013 | 450 | 0.120 |
Why?
|
| Exodeoxyribonuclease V | 3 | 2003 | 30 | 0.110 |
Why?
|
| Homologous Recombination | 2 | 2012 | 187 | 0.110 |
Why?
|
| DNA Breaks | 1 | 2013 | 38 | 0.110 |
Why?
|
| Protein Engineering | 1 | 2013 | 100 | 0.110 |
Why?
|
| Likelihood Functions | 2 | 2011 | 241 | 0.110 |
Why?
|
| Oxygen | 1 | 2018 | 792 | 0.110 |
Why?
|
| Alleles | 5 | 2012 | 2602 | 0.110 |
Why?
|
| Cell Division | 4 | 2019 | 2657 | 0.110 |
Why?
|
| Loss of Heterozygosity | 1 | 2015 | 623 | 0.110 |
Why?
|
| Animals | 11 | 2023 | 62048 | 0.110 |
Why?
|
| Ribonucleases | 1 | 2013 | 96 | 0.110 |
Why?
|
| Serine Endopeptidases | 3 | 2010 | 275 | 0.110 |
Why?
|
| Lactose | 2 | 2004 | 68 | 0.100 |
Why?
|
| DNA, Single-Stranded | 1 | 2013 | 124 | 0.100 |
Why?
|
| DNA Polymerase III | 2 | 2010 | 31 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2010 | 12102 | 0.100 |
Why?
|
| Chromosome Pairing | 1 | 2011 | 8 | 0.100 |
Why?
|
| Base Pair Mismatch | 3 | 2001 | 82 | 0.100 |
Why?
|
| Phylogeny | 2 | 2011 | 867 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2011 | 471 | 0.100 |
Why?
|
| Fungi | 1 | 1992 | 147 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 3 | 2005 | 427 | 0.090 |
Why?
|
| Cell Nucleus | 2 | 2024 | 1712 | 0.090 |
Why?
|
| Ciprofloxacin | 2 | 2023 | 90 | 0.090 |
Why?
|
| Chromosome Inversion | 1 | 2011 | 197 | 0.090 |
Why?
|
| Models, Biological | 3 | 2010 | 3194 | 0.090 |
Why?
|
| Ecosystem | 1 | 2011 | 119 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 371 | 0.090 |
Why?
|
| Microbial Viability | 1 | 2010 | 64 | 0.090 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 2010 | 58 | 0.090 |
Why?
|
| Humans | 22 | 2022 | 270802 | 0.090 |
Why?
|
| Bayes Theorem | 2 | 2011 | 1060 | 0.080 |
Why?
|
| Meiosis | 3 | 2024 | 175 | 0.080 |
Why?
|
| Transcription Factors | 4 | 2022 | 5440 | 0.080 |
Why?
|
| Gene Duplication | 1 | 2011 | 442 | 0.080 |
Why?
|
| Mutagenicity Tests | 1 | 2008 | 70 | 0.080 |
Why?
|
| Yeasts | 1 | 2009 | 76 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 1028 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 680 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 693 | 0.080 |
Why?
|
| Genetic Markers | 1 | 2011 | 1075 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 1642 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2013 | 820 | 0.080 |
Why?
|
| Endodeoxyribonucleases | 2 | 2024 | 116 | 0.070 |
Why?
|
| Fanconi Anemia Complementation Group G Protein | 1 | 2006 | 3 | 0.070 |
Why?
|
| Peroxidases | 1 | 2006 | 30 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 1472 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 3341 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2011 | 697 | 0.070 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 2 | 2003 | 12 | 0.070 |
Why?
|
| MutL Proteins | 2 | 2003 | 30 | 0.070 |
Why?
|
| Fanconi Anemia | 1 | 2006 | 90 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2006 | 417 | 0.060 |
Why?
|
| Chromosome Duplication | 2 | 2019 | 157 | 0.060 |
Why?
|
| Smith-Magenis Syndrome | 2 | 2019 | 126 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2004 | 329 | 0.060 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2004 | 58 | 0.060 |
Why?
|
| Kinetics | 2 | 2004 | 2221 | 0.060 |
Why?
|
| Geologic Sediments | 1 | 2003 | 9 | 0.060 |
Why?
|
| Air Microbiology | 1 | 2003 | 24 | 0.060 |
Why?
|
| Water Microbiology | 1 | 2003 | 29 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 4645 | 0.060 |
Why?
|
| Guanosine Tetraphosphate | 1 | 2023 | 6 | 0.060 |
Why?
|
| Gene Deletion | 3 | 2011 | 1473 | 0.050 |
Why?
|
| Chromosome Disorders | 2 | 2019 | 423 | 0.050 |
Why?
|
| Plasmids | 3 | 2009 | 936 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 121 | 0.050 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2023 | 123 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 174 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 152 | 0.050 |
Why?
|
| Genes, Fungal | 2 | 2008 | 94 | 0.050 |
Why?
|
| Salmonella | 1 | 2000 | 36 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 2351 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2000 | 453 | 0.040 |
Why?
|
| Bacteria | 1 | 2004 | 653 | 0.040 |
Why?
|
| Mitochondria | 1 | 2006 | 1299 | 0.040 |
Why?
|
| Abnormalities, Multiple | 2 | 2019 | 1023 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2019 | 103 | 0.040 |
Why?
|
| Phleomycins | 1 | 2018 | 6 | 0.040 |
Why?
|
| Genotype | 3 | 2015 | 4255 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2019 | 114 | 0.040 |
Why?
|
| Exonucleases | 1 | 2018 | 52 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 2357 | 0.040 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 89 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 2308 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2003 | 1570 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 246 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2013 | 1685 | 0.040 |
Why?
|
| Rad51 Recombinase | 1 | 2016 | 125 | 0.030 |
Why?
|
| Bacteriophage P1 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Ethylnitrosourea | 1 | 2015 | 20 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2013 | 909 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 90 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 290 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1998 | 409 | 0.030 |
Why?
|
| Synthetic Biology | 1 | 2013 | 15 | 0.030 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2013 | 88 | 0.030 |
Why?
|
| Ku Autoantigen | 1 | 2013 | 82 | 0.030 |
Why?
|
| Cytidine Deaminase | 1 | 2013 | 84 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 3478 | 0.030 |
Why?
|
| Fish Proteins | 1 | 2011 | 6 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2011 | 23 | 0.020 |
Why?
|
| Genetic Speciation | 1 | 2011 | 28 | 0.020 |
Why?
|
| Phylogeography | 1 | 2011 | 18 | 0.020 |
Why?
|
| Recombinases | 1 | 2011 | 40 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2011 | 225 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 1958 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 288 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2011 | 242 | 0.020 |
Why?
|
| Head | 1 | 2011 | 248 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2010 | 84 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 877 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 341 | 0.020 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2011 | 307 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 460 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 250 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 159 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 1988 | 52 | 0.020 |
Why?
|
| Mice | 2 | 2023 | 35597 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2012 | 458 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1993 | 1285 | 0.020 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2007 | 35 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2008 | 381 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2008 | 749 | 0.020 |
Why?
|
| Peroxiredoxin III | 1 | 2006 | 2 | 0.020 |
Why?
|
| Peroxiredoxins | 1 | 2006 | 18 | 0.020 |
Why?
|
| Time Factors | 1 | 2000 | 13021 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 175 | 0.020 |
Why?
|
| Calpain | 1 | 2006 | 70 | 0.020 |
Why?
|
| Peroxidase | 1 | 2006 | 133 | 0.020 |
Why?
|
| COS Cells | 1 | 2006 | 417 | 0.020 |
Why?
|
| DNA, Catenated | 1 | 2005 | 3 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 223 | 0.020 |
Why?
|
| DNA, Superhelical | 1 | 2005 | 28 | 0.020 |
Why?
|
| Mitomycin | 1 | 2006 | 213 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2008 | 704 | 0.020 |
Why?
|
| Proteins | 1 | 2013 | 2043 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 589 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2008 | 757 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2011 | 1624 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3346 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 704 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2006 | 331 | 0.020 |
Why?
|
| F Factor | 1 | 2004 | 3 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 3900 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 1121 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2005 | 494 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 538 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 742 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2009 | 3588 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 3215 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2009 | 2422 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 4134 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2006 | 1275 | 0.010 |
Why?
|
| Sildenafil Citrate | 1 | 2001 | 53 | 0.010 |
Why?
|
| Sulfones | 1 | 2001 | 145 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2006 | 1656 | 0.010 |
Why?
|
| Interphase | 1 | 1999 | 156 | 0.010 |
Why?
|
| Purines | 1 | 2001 | 271 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 9474 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 588 | 0.010 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 1998 | 200 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 13989 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2001 | 1193 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 17048 | 0.010 |
Why?
|
| Piperazines | 1 | 2001 | 2145 | 0.010 |
Why?
|
| Child | 1 | 2011 | 30546 | 0.010 |
Why?
|
| Male | 1 | 2011 | 128397 | 0.000 |
Why?
|
| Female | 1 | 2011 | 148967 | 0.000 |
Why?
|